TR199800022T1 - Yeni kuinoksalin ve kuinoksalinil alkalen-fosfonik asitler. - Google Patents
Yeni kuinoksalin ve kuinoksalinil alkalen-fosfonik asitler.Info
- Publication number
- TR199800022T1 TR199800022T1 TR1998/00022T TR9800022T TR199800022T1 TR 199800022 T1 TR199800022 T1 TR 199800022T1 TR 1998/00022 T TR1998/00022 T TR 1998/00022T TR 9800022 T TR9800022 T TR 9800022T TR 199800022 T1 TR199800022 T1 TR 199800022T1
- Authority
- TR
- Turkey
- Prior art keywords
- independently
- etherized
- phosphonic acids
- quinoxalinyl
- alkaline
- Prior art date
Links
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title abstract 4
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 title 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH200995 | 1995-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199800022T1 true TR199800022T1 (xx) | 1998-05-21 |
Family
ID=4223780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1998/00022T TR199800022T1 (xx) | 1995-07-10 | 1996-07-01 | Yeni kuinoksalin ve kuinoksalinil alkalen-fosfonik asitler. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0837864A1 (xx) |
| JP (1) | JPH11508902A (xx) |
| KR (1) | KR19990028839A (xx) |
| AU (1) | AU6516296A (xx) |
| BR (1) | BR9609644A (xx) |
| CA (1) | CA2224718A1 (xx) |
| CZ (1) | CZ5398A3 (xx) |
| HU (1) | HUP9901345A3 (xx) |
| IL (1) | IL122872A0 (xx) |
| NO (1) | NO980095L (xx) |
| PL (1) | PL324340A1 (xx) |
| SK (1) | SK2798A3 (xx) |
| TR (1) | TR199800022T1 (xx) |
| WO (1) | WO1997003079A1 (xx) |
| ZA (1) | ZA965800B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2264171T3 (es) * | 1996-10-24 | 2006-12-16 | Novartis Ag | Acidos aminoalcanofosfonicos sustituidos. |
| US6841684B2 (en) | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
| US6329369B1 (en) | 1997-12-04 | 2001-12-11 | Allergan Sales, Inc. | Methods of treating pain and other conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118675A (en) * | 1991-02-15 | 1992-06-02 | American Home Products Corporation | Quinoxaline phosphono-amino acids |
| IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1996
- 1996-07-01 PL PL96324340A patent/PL324340A1/xx unknown
- 1996-07-01 BR BR9609644A patent/BR9609644A/pt not_active Application Discontinuation
- 1996-07-01 CZ CZ9853A patent/CZ5398A3/cs unknown
- 1996-07-01 CA CA002224718A patent/CA2224718A1/en not_active Abandoned
- 1996-07-01 TR TR1998/00022T patent/TR199800022T1/xx unknown
- 1996-07-01 WO PCT/EP1996/002866 patent/WO1997003079A1/en not_active Application Discontinuation
- 1996-07-01 SK SK27-98A patent/SK2798A3/sk unknown
- 1996-07-01 IL IL12287296A patent/IL122872A0/xx unknown
- 1996-07-01 AU AU65162/96A patent/AU6516296A/en not_active Abandoned
- 1996-07-01 JP JP9505465A patent/JPH11508902A/ja active Pending
- 1996-07-01 KR KR1019980700140A patent/KR19990028839A/ko not_active Application Discontinuation
- 1996-07-01 HU HU9901345A patent/HUP9901345A3/hu unknown
- 1996-07-01 EP EP96924829A patent/EP0837864A1/en not_active Withdrawn
- 1996-07-09 ZA ZA965800A patent/ZA965800B/xx unknown
-
1998
- 1998-01-09 NO NO980095A patent/NO980095L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK2798A3 (en) | 1998-07-08 |
| NO980095D0 (no) | 1998-01-09 |
| IL122872A0 (en) | 1998-08-16 |
| JPH11508902A (ja) | 1999-08-03 |
| CA2224718A1 (en) | 1997-01-30 |
| MX9800332A (es) | 1998-07-31 |
| KR19990028839A (ko) | 1999-04-15 |
| NO980095L (no) | 1998-03-05 |
| AU6516296A (en) | 1997-02-10 |
| HUP9901345A2 (hu) | 1999-08-30 |
| PL324340A1 (en) | 1998-05-25 |
| CZ5398A3 (cs) | 1998-06-17 |
| WO1997003079A1 (en) | 1997-01-30 |
| BR9609644A (pt) | 1999-05-11 |
| ZA965800B (en) | 1997-01-10 |
| HUP9901345A3 (en) | 2000-01-28 |
| EP0837864A1 (en) | 1998-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE325128T1 (de) | Substituierte aminoalkanphosphonsäuren | |
| ATE196629T1 (de) | Derivate von benzosulfonamiden als hemmer des enzym cyclooxygenase ii | |
| TR199801419T2 (xx) | S�lfone amino asit t�revleri ve ayn� i�erikte metaloproteinez �nleyicileri. | |
| TR199800518T1 (xx) | Se�imli beta3 adrenerjik agonistler. | |
| TR199801195T2 (xx) | Tedavide yararl� kinolin ve kinozilin bile�ikleri. | |
| ATE184589T1 (de) | Nitroverbindingen und ihre zubereitungen mit entzündungsremmenden, schmertzlindernden und antithrombotischen wirkungen | |
| DK0526488T3 (da) | Benzylphosphonsyre-tyrosinkinaseinhibitorer | |
| ATE212847T1 (de) | Verwendung von phenol substituierten diphosphonaten als antineoplastische substanten | |
| ATE481417T1 (de) | Modifiziertes avidin und streptavidin und methoden zu ihrer verwendung | |
| TR199802296T2 (xx) | Yeni 2,3 dis�bstit�te-4 (3H)-kinazolinonlar | |
| WO2001039721A3 (en) | Modified starch solutions and their use in personal care | |
| DE69815311D1 (de) | Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii | |
| TR199901604T2 (xx) | Tedavide yararl� kinolin ve kinazolin bile�ikleri. | |
| FR2659228B1 (fr) | Procede de teinture des fibres keratiniques avec des 6 ou 7-monohydroxy-indoles a ph acide et compositions mises en óoeuvre. | |
| TR199800623T2 (xx) | Yeni amino asit t�revleri, m�stahzarlar� ve kullan�mlar�. | |
| TR199800022T1 (xx) | Yeni kuinoksalin ve kuinoksalinil alkalen-fosfonik asitler. | |
| TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
| TR200002893A2 (tr) | Kinolin-4-il türevleri II | |
| ES8504109A1 (es) | Procedimiento de producir compuestos para el tratamiento de la hipertension | |
| FI950094A (fi) | Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi | |
| AU3264195A (en) | Amino acid conjugate | |
| ATE280159T1 (de) | Aromatische carbonsäureester, ihre herstellung und verwendung als heilmittel | |
| TR199800410T1 (xx) | Yeni karboksilik asit t�revleri, haz�rlanmalar� ve kullan�mlar�. | |
| DE69925158D1 (de) | Zusammensetzung zur behandlung von verbrennungen | |
| Morell et al. | Dehydroascorbate reduction: the phantom remaining |